Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01116336
Title Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University, Astellas Pharma Inc, Polyphenon Pharma
Age Groups: adult
Covered Countries USA

No variant requirements are available.